The American journal of sports medicine · 2026
Borderline Hip Dysplasia Not Associated With Significant Differences in Hip Survivorship or Patient-Reported Outcomes After Primary Hip Arthroscopy for Femoroacetabular Impingement Syndrome: A Propensity-Matched Cohort Study With Minimum 10-Year Follow-up.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chen Larry, Berzolla Emily, Lezak Bradley, Lee Sangmin, Kaplan Daniel J, Youm Thomas
Аннотация
BACKGROUND: Hip arthroscopy has demonstrated favorable short- and mid-term outcomes for femoroacetabular impingement syndrome (FAIS) in patients with borderline hip dysplasia (BHD). However, long-term outcomes in patients with FAIS and BHD treated with hip arthroscopy remain understudied.
PURPOSE: To evaluate hip survivorship and patient-reported outcomes (PROs) in patients with FAIS and BHD compared with those without BHD at a minimum 10-year follow-up.
STUDY DESIGN: Cohort Study; Level of evidence, 4.
METHODS: A retrospective matched-cohort study was conducted on patients undergoing primary hip arthroscopy for FAIS by a single surgeon (2012-2024). BHD was defined as a lateral center-edge angle (LCEA) of 20° to 25°. Patients with BHD were matched 1 to 2 to controls without BHD based on age, sex, body mass index, and preoperative modified Harris Hip Score (mHHS). Radiographic parameters (eg, alpha angle, LCEA) were assessed pre- and postoperatively. PROs-including mHHS, Non-Arthritic Hip Score (NAHS), and hip survivorship (revision arthroscopy, conversion to total hip arthroplasty [THA])-were compared.
RESULTS: The study included 23 patients with BHD (mean age, 33.6 years; 69.6% women) and 46 controls (mean age, 32.7 years; 65.2% women). Both groups showed significant improvements in mHHS and NAHS at 10 years (all P < .001), with no differences in postoperative scores or minimal clinically important difference achievement (BHD group, 91.3% vs control group, 97.5%; P = .55). There were no conversions to THA in the BHD group and 2 in the control group (4.3%; P = .189). Revision arthroscopy rates were 0% in the BHD group and 8.7% in the control group (P = .549). Patients with BHD exhibited significantly greater reductions in alpha angles on 45° Dunn views (-13° vs -1.9°; P = .01).
CONCLUSION: At a minimum 10-year follow-up, patients with BHD who underwent hip arthroscopy for FAIS achieved comparable PROs and hip survivorship to those without BHD. These findings support the use of hip arthroscopy as a durable and effective treatment for FAIS in this population.
PURPOSE: To evaluate hip survivorship and patient-reported outcomes (PROs) in patients with FAIS and BHD compared with those without BHD at a minimum 10-year follow-up.
STUDY DESIGN: Cohort Study; Level of evidence, 4.
METHODS: A retrospective matched-cohort study was conducted on patients undergoing primary hip arthroscopy for FAIS by a single surgeon (2012-2024). BHD was defined as a lateral center-edge angle (LCEA) of 20° to 25°. Patients with BHD were matched 1 to 2 to controls without BHD based on age, sex, body mass index, and preoperative modified Harris Hip Score (mHHS). Radiographic parameters (eg, alpha angle, LCEA) were assessed pre- and postoperatively. PROs-including mHHS, Non-Arthritic Hip Score (NAHS), and hip survivorship (revision arthroscopy, conversion to total hip arthroplasty [THA])-were compared.
RESULTS: The study included 23 patients with BHD (mean age, 33.6 years; 69.6% women) and 46 controls (mean age, 32.7 years; 65.2% women). Both groups showed significant improvements in mHHS and NAHS at 10 years (all P < .001), with no differences in postoperative scores or minimal clinically important difference achievement (BHD group, 91.3% vs control group, 97.5%; P = .55). There were no conversions to THA in the BHD group and 2 in the control group (4.3%; P = .189). Revision arthroscopy rates were 0% in the BHD group and 8.7% in the control group (P = .549). Patients with BHD exhibited significantly greater reductions in alpha angles on 45° Dunn views (-13° vs -1.9°; P = .01).
CONCLUSION: At a minimum 10-year follow-up, patients with BHD who underwent hip arthroscopy for FAIS achieved comparable PROs and hip survivorship to those without BHD. These findings support the use of hip arthroscopy as a durable and effective treatment for FAIS in this population.